Search Results - "Bédossa, P"

MGMT expression predicts response to temozolomide in pancreatic neuroendocrine tumors by Cros, J, Hentic, O, Rebours, V, Zappa, M, Gille, N, Theou-Anton, N, Vernerey, D, Maire, F, Lévy, P, Bedossa, P, Paradis, V, Hammel, P, Ruszniewski, P, Couvelard, A

“…Temozolomide (TEM) showed encouraging results in well-differentiated pancreatic neuroendocrine tumors (WDPNETs). Low O6-methylguanine-DNA methyltransferase…”
Get full text

Changing trends in malignant transformation of hepatocellular adenoma by Farges, Olivier, Ferreira, Nelio, Dokmak, Safi, Belghiti, Jacques, Bedossa, Pierre, Paradis, Valérie

“…Hepatocellular adenomas (HCAs) classically develop in women who are taking oral contraceptives and have a risk of malignant transformation into hepatocellular…”
Get more information

An algorithm for the grading of activity in chronic hepatitis C by Bedossa, P, Poynard, T

“…Histological activity reflects the global assessment of basic necroinflammatory lesions and is a criterion of major importance in chronic hepatitis C. The aim…”
Get full text

An algorithm for the grading of activity in chronic hepatitis C by Bedossa, P, Poynard, T

“…Histological activity reflects the global assessment of basic necroinflammatory lesions and is a criterion of major importance in chronic hepatitis C. The aim…”
Get full text

Impact of controlled attenuation parameter on detecting fibrosis using liver stiffness measurement by Karlas, T., Petroff, D., Sasso, M., Fan, J.‐G., Mi, Y.‐Q., de Lédinghen, V., Kumar, M., Lupsor‐Platon, M., Han, K.‐H., Cardoso, A. C., Ferraioli, G., Chan, W.‐K., Wong, V. W.‐S., Myers, R. P., Chayama, K., Friedrich‐Rust, M., Beaugrand, M., Shen, F., Hiriart, J.‐B., Sarin, S. K., Badea, R., Lee, H. W., Marcellin, P., Filice, C., Mahadeva, S., Wong, G. L.‐H., Crotty, P., Masaki, K., Bojunga, J., Bedossa, P., Keim, V., Wiegand, J.

“…Summary Background Liver fibrosis is often accompanied by steatosis, particularly in patients with non‐alcoholic fatty liver disease (NAFLD), and its…”
Get full text

Diagnostic performance of FibroTest, SteatoTest and ActiTest in patients with NAFLD using the SAF score as histological reference by Munteanu, M., Tiniakos, D., Anstee, Q., Charlotte, F., Marchesini, G., Bugianesi, E., Trauner, M., Romero Gomez, M., Oliveira, C., Day, C., Dufour, J.‐F., Bellentani, S., Ngo, Y., Traussnig, S., Perazzo, H., Deckmyn, O., Bedossa, P., Ratziu, V., Poynard, T., Ratziu, Vlad, Poynard, Thierry, Castille, Jean‐Marie, Ngo, Yen, Langon, Tania, Day, Chris, Tiniakos, Dina, Lawlor, Debbie, Marchesini, Giulio, Marra, Fabio, Bugianesi, Elisabetta, Bellentani, Stefano, Dufour, Jean‐François, Romero Gomez, Manuel, Sørensen, Thorkild, Tribelli, Claudio, Minicis, Samuele, Trauner, Michael, Oliveira, Claudia, Bedossa, Pierre, Burt, Alastair D., Gouw, Annette S.H., Lackner, Carolin, Schirmacher, Peter, Terracciano, Luigi, Tiniakos, Dina, Brain, J., Bury, Yvonne, Cabibi, Daniela, Charlotte, Frederic, David, Ezio, Losi, Luisa, Montani, Matteo, Pareja, Marıa Jesus, Wendum, Dominique, Wrba, Fritz, Ziol, Marianne, Ratziu, Vlad, Poynard, Thierry, Ratziu, Vlad, Thabut, Dominique, Moussalli, Joseph, Lebray, Pascal, Rudler, Marika, Bismuth, Françoise Imbert, Charlotte, Frederic, Rosmorduc, Olivier, Calmus, Yvon, Hartemann, Agnes, Jacqueminet, Sophie, Bruckert, Eric, Giral, Philippe, Naveau, Sylvie, Perlemuter, Gabriel, Varsat, Brigitte, Mercadier, Anne

“…Summary Background Blood tests of liver injury are less well validated in non‐alcoholic fatty liver disease (NAFLD) than in patients with chronic viral…”
Get full text

Decision Tree for the Performance of Intraoperative Liver Biopsy During Bariatric Surgery by Barbois, Sandrine, Stürm, N., Aron-Wisnewsky, J., Clément, K., Bedossa, P., Genser, Laurent, Hilleret, M. N., Costentin, C., Reche, F., Arvieux, C., Borel, A. L.

“…Background and Aims Bariatric surgery provides a useful opportunity to perform intraoperative liver biopsy to screen for non-alcoholic steatohepatitis (NASH)…”
Get full text

Comparison of Classical and Novel Reliability Criteria for Accuracy of Transient Elastography in a Multicenter Prospective Cohort of Patients with Viral Hepatitis and Good Quality Liver Biopsies by Stern, C, Degos, F, Bedossa, P, Castera, L

Get full text

Pathological diagnosis of liver cell adenoma and focal nodular hyperplasia: Bordeaux update by Bioulac-Sage, P, Balabaud, C, Bedossa, P, Scoazec, J.Y, Chiche, L, Dhillon, A.P, Ferrell, L, Paradis, V, Roskams, T, Vilgrain, V, Wanless, I.R, Zucman-Rossi, J

Get full text

Gene expression and hepatitis C virus infection by Asselah, T, Bièche, I, Sabbagh, A, Bedossa, P, Moreau, R, Valla, D, Vidaud, M, Marcellin, P

“…Hepatitis C virus (HCV) is a major cause of chronic liver disease, with about 170 million people infected worldwide. Up to 70% of patients will have persistent…”
Get more information

Circumferential margin involvement after total mesorectal excision for mid or low rectal cancer: are all R1 resections equal? by Beaufrère, A., Guedj, N., Maggiori, L., Patroni, A., Bedossa, P., Panis, Y.

“…Aim Our aim was to assess the prognostic influence of the circumferential resection margin (CRM) exact value after total mesorectal excision for mid or low…”
Get full text

Fatty liver binding protein 4: a targetable adipokine in hepatocellular carcinoma related to metabolic syndrome by Laouirem, S, Albuquerque, M, Lagadec, F, Cros, J, Soubrane, O, Bedossa, P, Paradis, V

Get full text

Pathomolecular scoring and diagnostic algorithm of atypical hepatocellular adenomas: a clue for malignant transformation by Pote, N, Lagadec, F, Vernuccio, F, Bedossa, P, Vilgrain, V, Paradis, V

Get full text

Glypican-3 expression in hepatocellular tumors: diagnostic value for preneoplastic lesions and hepatocellular carcinomas by Wang, Xiao Ying, Degos, Françoise, Dubois, Sylvie, Tessiore, Sandrine, Allegretta, Mark, Guttmann, Ronald D., Jothy, Serge, Belghiti, Jacques, Bedossa, Pierre, Paradis, Valérie

“…Glypican-3 (GPC3), a member of heparan sulfate proteoglycans, plays a role in cell growth, differentiation, and migration. The objectives of this study were to…”
Get full text

Insulin resistance and geographical origin: major predictors of liver fibrosis and response to peginterferon and ribavirin in HCV-4 by Moucari, R, Ripault, M-P, Martinot-Peignoux, M, Voitot, H, Cardoso, A-C, Stern, C, Boyer, N, Maylin, S, Nicolas-Chanoine, M-H, Vidaud, M, Valla, D, Bedossa, P, Marcellin, P

“…Hepatitis C virus (HCV) genotype 4 (HCV-4) is increasing in prevalence in Western countries. However, little is known about the severity of the disease and…”
Get more information

Definition and natural history of metabolic steatosis: histology and cellular aspects by Paradis, V, Bedossa, P

“…Abstract In patients with diabetes and metabolic syndrome, liver changes may be observed on histology that are characterized as non-alcoholic fatty liver…”
Get full text

Cholangiopathy in critically ill patients surviving beyond the intensive care period: a multicentre survey in liver units by Laurent, L., Lemaitre, C., Minello, A., Plessier, A., Lamblin, G., Poujol‐Robert, A., Gervais‐Hasenknopf, A., Pariente, E.‐A., Belenotti, P., Mostefa‐Kara, N., Sogni, P., Legrand, M., Cournac, J.‐M., Tamion, F., Savoye, G., Bedossa, P., Valla, D.‐C., Vilgrain, V., Goria, O.

“…Summary Background The outcome of cholangiopathy developing in intensive care unit (ICU) is not known in patients surviving their ICU stay. Aim To perform a…”
Get full text

Reply to Wang and Kan by Beaufrère, A., Guedj, N., Maggiori, L., Patroni, A., Bedossa, P., Panis, Y.

Get full text

Comparison of liver biopsy and noninvasive techniques for liver fibrosis assessment in patients infected with HCV-genotype 4 in Egypt by Bonnard, P., Elsharkawy, A., Zalata, K., Delarocque-Astagneau, E., Biard, L., Le Fouler, L., Hassan, A. B., Abdel-Hamid, M., El-Daly, M., Gamal, M. E., El Kassas, M., Bedossa, P., Carrat, F., Fontanet, A., Esmat, G.

“…Summary In Egypt, as elsewhere, liver biopsy (LB) remains the gold standard to assess liver fibrosis in chronic hepatitis C (CHC) and is required to decide…”
Get full text

Performance of Fibroscan® in the Assessment of Non-Alcoholic Fatty Liver Disease/Non-Alcoholic Steatohepatitis Patients: Interim Results of a Prospective Multicentre Validation Study by Eddowes, P.J, Anstee, Q.M, Guha, I.N, Tsochatzis, E, Paradis, V, Bedossa, P, Newsome, P.N

Get full text